YY1 recruits BETs (including BRD2, BRD4) to bind to cis-regulatory elements of transcription factor 7 like 2 (TCF7L2), thereby regulating the expression of TCF7L2, cooperatively activating tumor cell DNA repair capacity and driving therapeutic resistance [88,89]. Here, TCF7L2 is linked to neoplasm.